Eye Health Supplement

Preservision AREDS 2 Formula

758 adverse event reports submitted to the FDA · 2014–2025 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 758 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Dysphagia
73
Macular degeneration
59
Foreign body
48
Choking
47
Blood pressure increased
42
Condition aggravated
41
Nausea
38
Cataract
32
Diarrhoea
32
Dizziness
30

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Other Serious or Important Medical Event 630
Hospitalization 111
Visited a Health Care Provider 76
Death 60
Visited Emergency Room 15
Disability 7
Life Threatening 5
Other Serious Outcome 4
Injury 2
Congenital Anomaly 1
Required Intervention 1
Other Outcome 1
Allergic Reaction 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
1
18–34
2
35–49
2
50–64
10
65–79
168
80+
319
Unknown
256

502 reports had age data; 256 unknown.

Gender

Female
520
Male
228
Unknown/Not Reported
10

Reports by Year

Annual report counts from 2014–2025. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Hover bars for exact counts.

← View all PreserVision AREDS 2 products in FDA data

Related Products

Preservision AREDS 2 (968)

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data